UNS Share Price

Open 0.05 Change Price %
High 0.06 1 Day 0.00 0.00
Low 0.05 1 Week 0.00 0.00
Close 0.06 1 Month 0.00 0.00
Volume 130013 1 Year -0.10 -62.50
52 Week High 0.38
52 Week Low 0.04
UNS Important Levels
Resistance 2 0.07
Resistance 1 0.07
Pivot 0.06
Support 1 0.05
Support 2 0.05
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
GPP 0.03 0.00%
PDN 0.06 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
GMR 0.01 0.00%
GMR 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RMG 0.02 100.00%
RMG 0.02 100.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
RHT 0.03 50.00%
RHT 0.03 50.00%
BMN 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GTG 0.01 -50.00%
RFT 0.02 -33.33%
AVX 0.02 -33.33%
AVX 0.02 -33.33%
AVX 0.02 -33.33%
More..

Unilife Corp (ASX: UNS)

UNS Technical Analysis 2
As on 2nd Dec 2016 UNS Share Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.12 & Buy for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
UNS Target for December
1st Target up-side 0.07
2nd Target up-side 0.08
3rd Target up-side 0.09
1st Target down-side 0.05
2nd Target down-side 0.04
3rd Target down-side 0.03
UNS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.unilife.com
UNS Address
UNS
250 Cross Farm Lane
York, PA 17406
United States
Phone: 717-384-3400
Fax: 717-384-3401
UNS Latest News
Penny Stock Drawing Interest: Focus On Unilife Corporation (NASDAQ:UNIS)   Duncan Research   - 02nd Dec 16
Trend Indicator Update on Unilife Corporation (UNIS)   MicroCap Wired   - 01st Dec 16
Brokerage Analysts Set Their Aim on Unilife Corporation (NASDAQ:UNIS)   Engelwood Daily   - 30th Nov 16
Earnings Action: Analysis and Unilife Corp (UNIS) Earnings Review   MoneyMakingArticles   - 27th Nov 16
Unilife Appoints Rosemary Crane and Duane DeSisto to its Board of Directors ...   PR Newswire (press release)   - 31st Oct 16
Unilife Announces Filing of 2016 10-K   PR Newswire (press release)   - 24th Oct 16
Unilife Corporation Announces Receipt of Delinquency Letter from NASDAQ ...   PR Newswire (press release)   - 24th Sep 16
Unilife Corp. (UNIS) Names New CEO; Updates on Cost Reduction Initiatives ...   StreetInsider.com   - 28th Jul 16
Unilife Corporation Announces Receipt of Deficiency Letter from NASDAQ   PR Newswire (press release)   - 24th May 16
Unilife and Amgen Enter Strategic Collaboration for Injectable Drug Delivery ...   PR Newswire (press release)   - 22nd Feb 16
Interactive Technical Analysis Chart Unilife Corp ( UNS ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Unilife Corp
UNS Business Profile
Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The company offers Unifill Syringe, a staked (fixed) retracting needle that is designed for use with liquid stable drugs; Unifill Select for use of liquid stable drug or vaccine, or a diluent to reconstitute and deliver a lyophilized drug supplied in a vial; and Unifill Assure, a finger flange and a thumb press for the intuitive self-injection of biologics. It also provides Rita disposable auto-injector that is designed to inject the prefilled dose from a single Unifill syringe; and Lisa reusable auto-injector, which automates the removal of the needle shield and enhances needle insertion and retraction, as well as EZMix dual or multi-chamber prefilled syringe for the reconstitution and delivery of injectable therapies. In addition, the company offers the Ocu-ject, a device for the delivery of microliter sized doses of drugs; and Depot-ject, a device that is designed to enable the precise placement of a drug depot into the vitreous of the eye, as well as Micro-ject, a device for optimizing the delivery of drugs with microliter doses that are unsuited to conventional device technologies. Its customers include pharmaceutical and biotechnology companies. The company is headquartered in York, Pennsylvania.